RT Journal Article
SR Electronic
T1 SARS-CoV-2 infection of the placenta
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.30.20083907
DO 10.1101/2020.04.30.20083907
A1 Hosier, Hillary
A1 Farhadian, Shelli
A1 Morotti, Raffaella A.
A1 Deshmukh, Uma
A1 Lu-Culligan, Alice
A1 Campbell, Katherine H.
A1 Yasumoto, Yuki
A1 Vogels, Chantal B.F.
A1 Casanovas-Massana, Arnau
A1 Vijayakumar, Pavithra
A1 Geng, Bertie
A1 Odio, Camila D.
A1 Fournier, John
A1 Brito, Anderson F.
A1 Fauver, Joseph R.
A1 Liu, Feimei
A1 Alpert, Tara
A1 Tal, Reshef
A1 Szigeti-Buck, Klara
A1 Perincheri, Sudhir
A1 Larsen, Christopher
A1 Gariepy, Aileen M.
A1 Aguilar, Gabriela
A1 Fardelmann, Kristen L.
A1 Harigopal, Malini
A1 Taylor, Hugh S.
A1 Pettker, Christian M.
A1 Wyllie, Anne L.
A1 Cruz, Charles Dela
A1 Ring, Aaron M.
A1 Grubaugh, Nathan D.
A1 Ko, Albert I.
A1 Horvath, Tamas L.
A1 Iwasaki, Akiko
A1 Reddy, Uma M.
A1 Lipkind, Heather S.
YR 2020
UL http://medrxiv.org/content/early/2020/05/07/2020.04.30.20083907.abstract
AB Background The effects of Covid-19 in pregnancy remain relatively unknown. We present a case of second trimester pregnancy with symptomatic Covid-19 complicated by severe preeclampsia and placental abruption.Methods We analyzed placenta for the presence of SARS-CoV-2 through molecular and immunohistochemical assays and by and electron microscopy, and we measured the maternal antibody response in blood to this infection.Results SARS-CoV-2 localized predominantly to syncytiotrophoblast cells at the maternal-fetal interface of the placenta. Histological examination of the placenta revealed a dense macrophage infiltrate, but no evidence for vasculopathy typically associated with preeclampsia.Conclusion This case demonstrates, for the first time, SARS-CoV-2 invasion of the placenta, highlighting the potential for severe morbidity among pregnant women with Covid-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdata links in manuscript (sequencing)